Development of Protein Capsular Matrix Vaccine (PCMV) Platform Technology

This podcast features:
Kevin Killeen, Vice President Research. Matrivax Research and Development Corp.
[sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Vaccines/TASCAM_0063.mp3″]

 


 

This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting the development and manufacture of biotherapeutics.

The 2013 BioProcess Theater consisted of five main presentation tracks: Biosimilars, Single-Use Processing, Cell Therapy, Antibody/Non-Antibody Manufacturing, and Vaccine Manufacturing.

If you would like more information on these presentations, please email us: info@bioprocessintl.com